Yumiko Kimura Selected Research

Yumiko Kimura Research Topics

Disease

19	Neoplasms (Cancer) 01/2020 - 02/2002
13	Carcinogenesis 01/2020 - 01/2004
4	Inflammation (Inflammations) 01/2009 - 02/2002
4	Neuroblastoma 04/2008 - 08/2005
3	Experimental Melanoma 01/2010 - 01/2009
2	Infections 01/2017 - 01/2009
2	Melanoma (Melanoma, Malignant) 08/2010 - 12/2006
2	Pulmonary Tuberculosis 09/2007 - 07/2007
2	Leukemia 12/2006 - 08/2005
1	Lymphadenopathy 09/2022
1	Arthritis (Polyarthritis) 09/2022
1	Chickenpox 09/2022
1	Fever (Fevers) 09/2022
1	Herpes Zoster 09/2022
1	Coinfection 09/2022
1	Breast Neoplasms (Breast Cancer) 01/2020
1	Pneumonia (Pneumonitis) 01/2017
1	Lung Neoplasms (Lung Cancer) 02/2011
1	Bacteremia 01/2009
1	Interstitial Lung Diseases (Interstitial Lung Disease) 01/2008
1	Liver Failure 09/2007
1	Multidrug-Resistant Tuberculosis (Drug-Resistant Tuberculosis) 07/2007
1	Colonic Neoplasms (Colon Cancer) 12/2006
1	Rheumatoid Arthritis 09/2006

Drug/Important Bio-Agent (IBA)

9	anthraceneIBA 06/2012 - 10/2005
8	TriterpenesIBA 10/2009 - 03/2002
7	AcidsIBA 10/2009 - 03/2002
3	ChalconesIBA 02/2012 - 01/2006
3	Melanins (Melanin)IBA 01/2010 - 01/2009
3	Peroxynitrous Acid (Peroxynitrite)IBA 01/2009 - 10/2005
3	Chalcone (Benzalacetophenone)IBA 04/2008 - 08/2005
3	xanthoangelolIBA 04/2008 - 08/2005
3	Epstein-Barr virus early antigenIBA 09/2006 - 02/2002
2	SteroidsIBA 01/2008 - 09/2007
2	isobavachalconeIBA 10/2007 - 01/2006
2	Caspase 3 (Caspase-3)IBA 10/2007 - 08/2005
2	cucurbitaneIBA 08/2007 - 02/2002
2	GlycosidesIBA 12/2006 - 02/2002
2	lupaneIBA 09/2006 - 03/2002
1	AutoantibodiesIBA 09/2022
1	Ethambutol (Myambutol)FDA LinkGeneric 09/2022
1	InterferonsIBA 09/2022
1	Clarithromycin (Biaxin)FDA LinkGeneric 09/2022
1	Rifabutin (Ansamycin)FDA Link 09/2022
1	CaspasesIBA 01/2020
1	Trypan Blue FDA Link 01/2020
1	Proteins (Proteins, Gene)FDA Link 01/2020
1	Small Interfering RNA (siRNA)IBA 01/2020
1	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 01/2017
1	5-deprenyllupulonol CIBA 06/2012
1	6-prenylnaringeninIBA 06/2012
1	lupulonIBA 06/2012
1	poricotriol AIBA 02/2011
1	Amino Acids FDA Link 08/2010
1	alpha-MSHIBA 01/2010
1	25-methoxyporicoic acid AIBA 10/2009
1	azadirachtin BIBA 01/2009
1	3- (5- nitrofuryl)- 7- (5- nitrofurfurylidene)- 3,3a,4,5,6,7- hexahydro- 2H- indazoleIBA 01/2009
1	Reactive Oxygen Species (Oxygen Radicals)IBA 04/2008
1	BromidesIBA 10/2007
1	Caspase 9IBA 10/2007
1	diphenyl (biphenyl)IBA 10/2007
1	EstersIBA 05/2007
1	Fatty Acids (Saturated Fatty Acids)IBA 05/2007
1	SterolsIBA 02/2007
1	cembraneIBA 09/2006
1	DiterpenesIBA 09/2006
1	tirucallaneIBA 09/2006
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 09/2006
1	oleananeIBA 09/2006
1	1,3- dihydroxy- 4,4,5,5- tetramethyl- 2- (4- carboxyphenyl)tetrahydroimidazole (NOR 1)IBA 09/2006
1	ursaneIBA 09/2006
1	acerogenin MIBA 05/2006
1	DiarylheptanoidsIBA 05/2006
1	monascinIBA 10/2005
1	euscaphic acidIBA 10/2005
1	9,10-Dimethyl-1,2-benzanthraceneIBA 01/2004
1	CarcinogensIBA 03/2002
1	betulinIBA 03/2002
1	betulonic acidIBA 03/2002
1	LupanesIBA 03/2002

Therapy/Procedure

3	Therapeutics 01/2017 - 12/2006
1	Aftercare (After-Treatment) 09/2022
1	Catheters 01/2009
1	Drug Therapy (Chemotherapy) 04/2008
1	Pneumonectomy (Lung Volume Reduction) 07/2007
1	Oral Administration 10/2005